If by “global compound intelligence” you mean comprehensive, worldwide coverage of new chemical entities across literature, patents, and preclinical/clinical data, here are the main databases and platforms often used in NCE work. I’ve grouped them by scope and access type.
General chemical and bioactive compound databases (globally curated, often used for NCE discovery)
- SciFinder-n (ACS): broad coverage of chemistry literature, reactions, properties, and patents (license required).
- Reaxys (Elsevier): global literature and patent data, reaction and property information (license required).
- PubChem (NCBI/NIH): open-access repository of structures, properties, and bioactivities; very global in scope.
- ChEMBL (EBI): curated bioactivity data for many drug-like molecules, including many NCEs; free access.
- DrugBank: curated collection of drugs and drug candidates with mechanisms and targets (free and licensed content available).
- ChemSpider (RSC): aggregated structure database with links to literature and other data sources (free).
- ZINC: free database of purchasable compounds for screening; useful for exploring global chemical space.
Patents and patent-derived global compound intelligence
- SureChEMBL: patent-derived chemical data linked to ChEMBL IDs; broad patent coverage.
- Patentscope (WIPO):全球专利搜索 with chemical structure searching capabilities; worldwide patent data.
- Espacenet (EPO): global patent search with chemical structure data and families.
- Lens.org: integrated patents, literature, and scholarly metadata with chemical search capabilities.
- Google Patents: broad, easy access to worldwide patents (useful for quick checks, not a replacement for specialized databases).
Bioactivity and target-focused resources (often used for NCE prioritization)
- BindingDB: binding affinity data for many targets; global scope.
- PDB and related resources: structural insights for target interactions (for structure-based design).
Clinical and regulatory context (global, cross-border)
- ClinicalTrials.gov: global registry of clinical studies for NCEs; useful for tracking development stages.
- Regulatory databases and dashboards offered by major vendors (often part of a Cortellis-style platform) for global approvals, INDs, and VHPs.
Enterprise/market intelligence platforms (explicit “global compound intelligence” offerings)
- Some vendors market a bundled “Global Compound Intelligence” capability as part of drug discovery or competitive intelligence suites. Examples include Clarivate Cortellis and similar platforms that integrate literature, patents, clinical data, and competitive landscape around NCEs. If you’re evaluating a platform, look for:
- Global patent coverage and structure-searchable data
- Literature with structure and substructure search
- Bioactivity/ADME/tox data
- Clinical and regulatory tracking
- Intuitive visualization and export options
A few quick tips
- If you need broad, free access: PubChem and ChEMBL are great starting points; supplement with SureChEMBL or Patentscope for patent coverage.
- For an in-depth, license-based workflow (most comprehensive): SciFinder-n and Reaxys plus a patent-focused resource (SureChEMBL, Patentscope, Espacenet) together cover literature, chemistry, and patents.
- For screening-ready compounds: ZINC (for purchasable compounds) plus PubChem/ChEMBL for activity data.
- For global competitive intelligence in industry settings: consider an integrated platform (e.g., Cortellis/Genome-driven intelligence suites) that brands itself as offering “global compound intelligence.”
Would you like me to tailor a recommended set based on your needs (free vs. licensed access, focus on patents vs. literature, specific targets, or a regional emphasis)?